Respect the specialty
Build around the capabilities, clinical judgment, and care relationships that make specialized apheresis services possible.
About Angeliki
A clear focus.
A long-term commitment.
Angeliki Apheresis is a U.S. healthcare holding company focused on acquiring, integrating, and expanding specialized apheresis clinics.
Our purpose
Build the business
behind the care.
Our ambition is to create an enduring apheresis platform with the operational foundations to support responsible growth.
We see ownership as an active responsibility. Our approach starts with understanding a clinic’s people, processes, clinical relationships, and economics, then designing a transition and operating plan around what that business needs.
Angeliki is developing its acquisition platform. This website describes our strategy and areas of interest; it does not present an existing network of operating clinics.
What guides us
Principles before scale.
Earn the right to grow
Evaluate clinical capacity, staffing, operating requirements, and financial discipline before pursuing expansion.
Think beyond the transaction
Plan the transition, accountability, and operating support that follow an acquisition from the outset.
Our structure
One company.
One specialized strategy.
Angeliki’s current strategy is that of a healthcare holding company, with a focused acquisition and integration plan for U.S. apheresis clinics.
Each potential acquisition will require its own diligence and structure, including review of the clinical entity, ownership, management arrangements, and applicable operating requirements.
How we intend to buildA conversation is the first step
Build the next chapter with us.
We welcome conversations with apheresis clinic owners and healthcare organizations who share our focus on specialized care.